摘要
目的观察非酒精性脂肪肝治疗中多烯磷脂酰胆碱胶囊与复方甘草酸苷联合应用的临床效果。方法以2017年12月~2021年12月中国人民解放军联勤保障部队第九四一医院收治的60例非酒精性脂肪肝患者为研究对象,将其按照随机数表法分成对照组与观察组,每组30例。对照组采用多烯磷脂酰胆碱胶囊治疗,观察组除应用多烯磷脂酰胆碱胶囊外,加用复方甘草酸苷治疗,观察两组治疗效果。结果观察组治疗有效率高于对照组(P<0.05)。治疗前,两组天门冬氨酸氨基转移酶(AST)、丙氨酸氨基转移酶(ALT)、总胆固醇(TC)、甘油三酯(TG)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)指标比较,差异无统计学意义(P>0.05);治疗后,观察组HDL-C高于对照组,AST、ALT、TC、TG、LDL-C低于对照组,差异有统计学意义(P<0.05)。两组治疗期间不良反应发生率比较,差异无统计学意义(P>0.05)。结论临床治疗非酒精性脂肪肝患者时,在多烯磷脂酰胆碱胶囊基础上加用复方甘草酸苷,可提高治疗效果,且患者肝功能、血脂指标均得到有效改善,利于疾病康复,同时患者用药后较少发生不良反应,安全性较高。
Objective To observe the clinical outcome of polyene phosphatidyl choline capsules combing compound glycyrrhizin in the treatment of non-alcoholic fatty liver disease.Methods 60 patients with non-alcoholic fatty liver disease in No.941 Hospital of PLA Logistic Support Troops from December 2017 to December 2021 were included in current studies.The patients were randomly divided into control group and observation group,and each group contained 30 patients.Patients in control group were treated with polyene phosphatidyl choline capsules while patients in observation group were administrated with polyene phosphatidyl choline capsules together with compound glycyrrhizin.The therapeutic outcome was observed herein.Results There were no remarkable alterations in the incidence of side eff ects during the treatment as well as aspartate aminotransferase(AST),alanine aminotransferase(ALT),total cholesterol(TC),triglyceride(TG),high density lipoprotein cholesterol(HDL-C),and low density lipoprotein cholesterol(LDL-C)before the treatment(P>0.05).After treatment,compared to control group,the total eff ective rate and HDL-C in observation group were increased,while AST,ALT,TC,TG and LDL-C were decreased signifi cantly(P<0.05).Conclusion Combination of polyene phosphatidyl choline capsules and compound glycyrrhizin in the treatment of non-alcoholic fatty liver disease could remarkable enhance the therapeutic outcome,improve liver function and blood lipids in patients,promote rehabilitation,and reduce side eff ects,which indicated the potential high safety.
作者
赵林
ZHAO Lin(Department of Infectious Diseases,No.941 Hospital of PLA Logistic Support Troops,Qinghai Xining,810007,China)
出处
《中华养生保健》
2022年第11期1-4,共4页
CHINESE HEALTH CARE
关键词
非酒精性脂肪肝
多烯磷脂酰胆碱胶囊
复方甘草酸苷
non-alcoholic fatty liver disease
polyene phosphatidyl choline capsules
compound glycyrrhizin
